Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Director/PDMR Shareholding

10 Aug 2011 07:00

RNS Number : 0554M
Gresham Computing PLC
10 August 2011
 

Gresham Computing plc

 

Director's Dealings

 

Gresham Computing plc (the "Company") has received notification that on 9 August 2011, Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), acquired 100,000 ordinary shares in the Company at a price of 46.65 pence per share and acquired 50,000 ordinary shares in the Company at a price of 45.00 pence per share.

 

Kestrel Partners LLP, which Max Royde (Non-executive Director of the Company) is a partner of and holds a beneficial interest in, is the investment manager to Kestrel Opportunities. Mr Royde is also a shareholder in Kestrel Opportunities.

 

Kestrel Opportunities holds 3,627,854 ordinary shares in the Company, which represents approximately 6.2 per cent of the Company's issued share capital.

 

-ends-

 

For further information please contact:

Gresham Computing plcChris Errington, CEOKen Archer, ChairmanRob Grubb, CFO

+44 (0) 20 7653 0200

Singer Capital Markets LtdShaun Dobson, Partner and Joint Head of Corporate FinanceJames Maxwell, Director of Corporate Finance

+44 (0) 20 3205 7500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSUFIUFFSEIA
Date   Source Headline
23rd Dec 20202:00 pmRNSSignificant Clareti Contract Win with Global Bank
11th Dec 20207:00 amRNSNotice of General Meeting and Circular
3rd Dec 202012:37 pmRNSExercise of Options
23rd Nov 20207:00 amRNSSignificant Clareti Contract with Global Bank
2nd Nov 20202:17 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSExercise of Options
12th Oct 20207:00 amRNSBoard Changes
5th Oct 20207:00 amRNSExercise of Options
23rd Sep 202012:24 pmRNSExercise of Options
15th Sep 20205:04 pmRNSHolding(s) in Company
30th Jul 202012:28 pmRNSChairman designate dealing
29th Jul 20207:00 amRNSAcquisition of Inforalgo Information Technology
28th Jul 20204:35 pmRNSHolding(s) in Company
28th Jul 20201:34 pmRNSHolding(s) in Company
21st Jul 20207:01 amRNSBoard Changes
21st Jul 20207:00 amRNSHalf-year Report
16th Jul 20207:00 amRNSNotice of Interim Results and Presentations
6th Jul 20201:42 pmRNSHolding(s) in Company
6th Jul 20201:40 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSTrading Update
11th Jun 20203:21 pmRNSHolding(s) in Company
10th Jun 202012:00 pmRNSSignificant Clareti Contract Win with Global Bank
4th Jun 202010:28 amRNSPDMR Dealing
19th May 20201:03 pmRNSHolding(s) in Company
14th May 202012:23 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
6th May 20207:00 amRNSAGM Change of Location
20th Apr 20207:00 amRNSTrading Update – COVID-19 Impact
2nd Apr 20207:00 amRNSNotice of AGM and Dividend Timetable
31st Mar 20207:00 amRNSDirectors Share Awards
27th Mar 20201:33 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20201:58 pmRNSUpdate on Private Investor Presentation
4th Mar 20207:00 amRNSNotice of Results & Analyst Presentation
3rd Feb 20207:00 amRNSElectronic Communications
28th Jan 20203:13 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSTrading Update
3rd Jan 20201:27 pmRNSHolding(s) in Company
27th Dec 20192:55 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSClareti Contract Win and Trading Update
25th Sep 20197:00 amRNSExercise of Options
20th Sep 20197:00 amRNSGresham and ANZ partnership
2nd Sep 201911:11 amRNSHolding(s) in Company
2nd Aug 20195:46 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNotice of Results & Analyst Presentation
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSStrategic fintech partner signs Clareti agreement
5th Jun 20199:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.